Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06982794

A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma

'UROLIFE': a Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
IRCCS San Raffaele · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to select contents and tools for the future development of a web app aiming to support patients' navigation for empowering decision-making through a higher awareness of urothelial carcinoma and its treatments, improving also educational aspects. The main question it aims to answer is: What are the contents that patients diagnosed with urothelial carcinoma find useful to include in a web app to streamline their quality of life assessment and monitoring? Participants candidate for systemic treatments, or already under treatment, will answer questionnaires about the tools to include in a web app designed for urothelial carcinoma.

Conditions

Timeline

Start date
2025-06-30
Primary completion
2025-09-30
Completion
2025-10-31
First posted
2025-05-21
Last updated
2025-05-21

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06982794. Inclusion in this directory is not an endorsement.

A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma (NCT06982794) · Clinical Trials Directory